ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANIP ANI Pharmaceuticals, Inc.

休市中 11-22 16:00:00 EST

56.91

+1.05

+1.88%

盘后56.91

+0.000.00%

16:02 EST

最高57.14	最低55.99	成交量13.18万
今开56.45	昨收55.86	日振幅2.05%
总市值11.97亿	流通市值9.14亿	总股本2,104万
成交额748.23万	换手率0.82%	流通股本1,605万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANIP","market":"US","secType":"STK","nameCN":"ANI Pharmaceuticals, Inc.","latestPrice":56.91,"timestamp":1732309200000,"preClose":55.86,"halted":0,"volume":131831,"hourTrading":{"tag":"盘后","latestPrice":56.91,"preClose":56.91,"latestTime":"16:02 EST","volume":4142,"amount":235720.65,"timestamp":1732309353903},"delay":0,"floatShares":16052400,"shares":21040933,"eps":1.183342,"marketStatus":"休市中","marketStatusCode":7,"change":1.05,"latestTime":"11-22 16:00:00 EST","open":56.45,"high":57.135,"low":55.99,"amount":7482295.813475,"amplitude":0.020498,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.183342,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1064980800000,"adjPreClose":55.86,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":56.5,"preClose":55.86,"latestTime":"09:21 EST","volume":700,"amount":38360.238,"timestamp":1732285261839},"postHourTrading":{"tag":"盘后","latestPrice":56.91,"preClose":56.91,"latestTime":"16:02 EST","volume":4142,"amount":235720.65,"timestamp":1732309353903},"volumeRatio":0.5108018090065962,"impliedVol":0.2429,"impliedVolPercentile":0.0437},"requestUrl":"/m/hq/s/ANIP/tweets","defaultTab":"tweets","newsList":[{"id":"2482201282","title":"美国研究综述-Akamai Technologies、Bill Holdings、Veeva Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2482201282","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482201282?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:08","pubTimestamp":1731308918,"startTime":"0","endTime":"0","summary":"美国研究综述-Akamai Technologies、Bill Holdings、Veeva Systems路透11月11日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Akamai Technologies、Bill Holdings 和 Veeva Systems。要闻  * Akamai Technologies Inc AKAM.O：汇丰银行将目标价从107美元上调至121美元 * Bill Holdings Inc BILL.N：杰富瑞将目标价从65美元上调至92美元 * Charles River Laboratories International CRL.N：TD Cowen将目标价从203美元上调至227美元 * Veeva Systems Inc VEEV.N：Jefferies 将目标价从 240 美元上调至 280 美元 * Xeris Biopharma Holdings Inc XERS.O：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4S3MI0GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERT","TKNO","AKAM","AFL","ACT","LU2552382215.SGD","AMP","CTKB","CRL","ENPH","BK4565","ADPT","APA","DOCS","COTY","EL","BAX","BK4528","EVH","BK4167","BHF","CBT","EXAS","CPAY","LU0511384066.AUD","CYBR","ANIP","BRX","BK4539","CIM","CACI","ATMU","BILL","BK4530","BK4077","BOW","DKNG","CRK","ALRM","LU0690374615.EUR","CUBE","CRBG","CNA","CELH","VEEV","BMBL","EXR","CUZ"],"gpt_icon":1},{"id":"1193537946","title":"异动解读 | ANI制药业绩超预期 股价盘前大涨8.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193537946","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193537946?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:24","pubTimestamp":1731083090,"startTime":"0","endTime":"0","summary":"在2024年11月8日盘前交易中,ANI Pharmaceuticals股价大涨8.77%,引发市场广泛关注。导致该公司股价大涨的主要原因是其第三季度财报数据超出华尔街分析师预期。具体来看,ANI制药在截至2024年9月30日的第三季度公布了亮眼的财务业绩。营收方面,ANI公司季度营收为1.4833亿美元,同比增长12.5%,也超出了分析师预期的1.4435亿美元。ANI制药优异的季度业绩受到了分析师界的积极评价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANIP"],"gpt_icon":0},{"id":"2482873489","title":"ANI 制药公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482873489","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482873489?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:21","pubTimestamp":1731082871,"startTime":"0","endTime":"0","summary":"ANI 制药公司公布截至 9 月 30 日的季度业绩 - 收益摘要ANI Pharmaceuticals Inc ANIP.OQ公布的截至9月30日的季度调整后每股收益为1.34美元，高于去年同期的每股收益1.27美元。该公司一季度亏损 2457 万美元。ANI Pharmaceuticals Inc本季度股价下跌了2.1%，今年迄今为止上涨了5.9%。华尔街对 ANI Pharmaceuticals Inc 的 12 个月目标价中位数为 83.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF1YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2474059637","title":"美国研究综述-ANI Pharmaceuticals、Deere & Co、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2474059637","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474059637?lang=zh_cn&edition=full","pubTime":"2024-10-11 15:47","pubTimestamp":1728632832,"startTime":"0","endTime":"0","summary":"    路透10月11日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 ANI 制药公司、迪尔公司和 Zoetis 公司。要闻 * ANI 制药公司   ：Piper Sandler给予该公司增持评级 * 迪尔公司   ：摩根大通将目标价从 360 美元上调至 420 美元 * Zoetis Inc   ：摩根大通将目标价从22美元上调至230美元 以下是路透周五报道的美国公司研究行动摘要。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CE","LU1868837136.USD","LU0690374961.EUR","LU0158827781.USD","DAL","LU0289739343.SGD","DE","LU0417517546.SGD","IE00BLSP4452.SGD","LU0208291251.USD","LU0128525689.USD","EWTX","LU1804176565.USD","BK4152","IDXX","SGXZ23171101.USD","WLK","LU2264538146.SGD","BK4524","LU1119994496.HKD","LU0058720904.USD","HUN","CC","BK4539","LU1989763690.USD","LU0097036916.USD","LU0158827948.USD","BK4500","LU0256863811.USD","DPZ","LU1983299246.USD","LU1989764664.SGD","ANIP","ISRG","NAPA","LU2271345857.HKD","LU1989763427.SGD","LU0310799852.SGD","LU0061475181.USD","ARHS","XNCR","FLUT","LU1244550494.USD","BK4082","LU0211326839.USD","ZTS","LU0971096721.USD","EMN"],"gpt_icon":1},{"id":"2468235532","title":"BUZZ--美国股票走势-英特尔、ANI 制药、纽约社区银行","url":"https://stock-news.laohu8.com/highlight/detail?id=2468235532","media":"Reuters","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468235532?lang=zh_cn&edition=full","pubTime":"2024-09-17 19:58","pubTimestamp":1726574315,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月17日 - 美国股指期货走高，原因是投资者在等待一系列经济数据，并对美联储将在周二开始的货币政策会议上大幅降息抱有希望。美东时间7:39 ，道指电子盘  上涨0.18%，报41,736 点。标普500指数小型股  上涨0.24%，报5,651.5点；纳斯达克100指数小型股  上涨0.41%，报19,513.5点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","IE00BWXC8680.SGD","LU0106261372.USD","VIGL","IE0004086264.USD","BK4554","BK4195","IE00B19Z9505.USD","IE00B894F039.SGD","BK4524","IE00BDRTCR15.USD","LU0823414478.USD","BK4516","BK4170","SEDG","VSAT","DCOM","IE00BFSS7M15.SGD","BK4581","IE0005OL40V9.USD","2NVD.UK","BK4532","BK4579","IE00BDCRKT87.USD","IE00BLSP4452.SGD","IE00BQXX3D17.EUR","IE00B3S45H60.SGD","IE00BMPRXQ63.HKD","ABNB","L","BK4571","LU0061475181.USD","3NVD.UK","BK4588","INTC","IE00BJTD4N35.SGD","ANIP","BK4505","BK4501","IE00B775SV38.USD","BK4534","NYCB","IE00BK4W5L77.USD","IE00BK4W5M84.HKD","IE00BQXX3C00.GBP","BK4512"],"gpt_icon":1},{"id":"2468584223","title":"BUZZ-Alimera 交易完成后，古根海姆上调 ANI 制药公司的预期收益率","url":"https://stock-news.laohu8.com/highlight/detail?id=2468584223","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468584223?lang=zh_cn&edition=full","pubTime":"2024-09-17 19:28","pubTimestamp":1726572511,"startTime":"0","endTime":"0","summary":"    9月17日 - ** 经纪公司古根海姆将ANI Pharmaceuticals   的PT值从77美元上调至83美元，维持 \"买入 \"评级** 新的PT较上一交易日收盘价上涨47.7 ** 称，在完成对Alimera公司的收购后更新了模型 ** 周一，ANIP宣布完成对Alimera Sciences   的收购，扩大了其罕见病业务。** 券商预计，Alimera 24财年的产品收入为3440万美元，其中包括ANIP将记录的2024年第三季度最后两周的410万美元销售额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP","ALIM","BK4007"],"gpt_icon":0},{"id":"2466528893","title":"美国研究综述-Adicet 生物公司、埃克森美孚公司、甲骨文公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2466528893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466528893?lang=zh_cn&edition=full","pubTime":"2024-09-11 20:00","pubTimestamp":1726056012,"startTime":"0","endTime":"0","summary":"    路透9月11日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Adicet Bio、埃克森美孚和甲骨文。* 埃克森美孚   ：Gerdes Energy Research将其评级从 \"中性 \"上调至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","AVBP","LU2023251221.USD","CNC","ANIP","CHTR","AQST","NTLA","DEI","XOM","BXP","ALLY","IE00B775SV38.USD","BKU","DHR","IE0034235188.USD","BK4550","ASO","ACET","DPZ","CAC","ORCL","AXON","HPP","CIVI","CPB","ESRT","BEAM","LU1861558580.USD","PLAY","CUZ","LU","CDP","APP","CABO","CTLP","CMA","DV","T","JBI","BBIO","CNOB","LU1691799644.USD","FDS","LU0390134368.USD","HIW","LU1861559042.SGD"],"gpt_icon":1},{"id":"2466456331","title":"BUZZ-Alimera Sciences 下定决心起诉 ANI Pharma 以完成交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2466456331","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466456331?lang=zh_cn&edition=full","pubTime":"2024-09-10 21:52","pubTimestamp":1725976364,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月10日 - ** 眼科药物开发商Alimera Sciences   股价下跌16.67%，至4.61美元** 公司在 (link) 提起诉讼，要求 ANI 制药公司  完成合并交易** 该诉讼要求法院要求 ANI 履行其义务，按照协议的设想完成交易** 两家公司于 6 月宣布 (link) 他们的协议，ALIM 的预付对价估值约为 3.81 亿美元。** ALIM 今年以来的涨幅约为 6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALIM","BK4007","ANIP"],"gpt_icon":0},{"id":"2458405692","title":"Ani Pharmaceuticals, Inc.2024财年第二财季实现净利润-2.29百万美元，同比减少136.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458405692","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458405692?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:12","pubTimestamp":1723392779,"startTime":"0","endTime":"0","summary":"8月12日，Ani Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-2.29百万美元，同比减少136.64%；其中营业收入为1.38亿美元，同比增加17.95%，每股基本收益为-0.14美元。从资产负债表来看，Ani Pharmaceuticals, Inc.总负债4.65亿美元，其中短期债务850000.00美元，资产负债比为1.99，流动比率为3.97。机构评级：截至2024年8月12日，当前有5家机构对Ani Pharmaceuticals, Inc.目标价做出预测，其中目标均价为83.40美元，其中最低目标价为77.00美元，最高目标价为94.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812001308959043b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812001308959043b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIP"],"gpt_icon":0},{"id":"2457844648","title":"Ani Pharmaceuticals, Inc.股价重挫14.11% 市值跌1.61亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457844648","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457844648?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:33","pubTimestamp":1723037638,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时33分，Ani Pharmaceuticals, Inc.股票出现波动，股价急速跳水14.11%。截至发稿，该股报54.36美元/股，成交量3.2304万股，换手率0.15%，振幅3.52%。Ani Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为1.47%。其相关个股中，Petiq, Inc.、Supernus Pharmaceuticals, Inc.、Aquestive Therapeutics, Inc.涨幅较大，Petiq, Inc.、苏轩堂、Sunshine Biopharma Inc.较为活跃，换手率分别为4.30%、1.94%、1.31%，振幅较大的相关个股有Supernus Pharmaceuticals, Inc.、德纳维制药、脑再生科技，振幅分别为14.10%、10.45%、7.97%。Ani Pharmaceuticals, Inc.公司简介：ANI Pharmaceuticals Inc 开发、制造和销售仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072133589f1775b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072133589f1775b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIP","BK4007"],"gpt_icon":0},{"id":"1191808843","title":"异动解读 | ANI Pharmaceuticals, Inc.盘中大涨6.36% 营收增长或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1191808843","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191808843?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:07","pubTimestamp":1722953229,"startTime":"0","endTime":"0","summary":"北京时间2024年8月6日,制药公司ANI Pharmaceuticals, Inc.(ANIP.US)股价盘中大涨6.36%,报收于62.22美元/股,成交量4164股。\n\n公司最新公布的2024年第二季度财报显示,尽管当季每股收益1.02美元低于去年同期的1.28美元,但营业收入同比增长18.4%至1.38亿美元,超出分析师预期。\n\n分析人士指出,ANI Pharmaceuticals的营收增长态势良好,可能是推动股价上涨的主要原因。不过,目前尚无其他直接相关新闻解释股价大涨的具体原因。投资者需继续关注公司后续发展动向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2457602344","title":"Ani Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457602344","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457602344?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:33","pubTimestamp":1722951209,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时33分，Ani Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.17%。截至发稿，该股报62.22美元/股，成交量4164股，换手率0.02%，振幅0.00%。Ani Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.88%。其相关个股中，Im Cannabis Corp.、和黄医药、Therapeuticsmd, Inc.涨幅较大，苏轩堂、Akanda Corp.、Redhill Biopharma Ltd较为活跃，换手率分别为4.24%、2.01%、1.67%，振幅较大的相关个股有Esperion Therapeutics, Inc.、Phibro Animal Health Corporation、Organon & Co.，振幅分别为4.55%、4.28%、4.21%。Ani Pharmaceuticals, Inc.公司简介：ANI Pharmaceuticals Inc 开发、制造和销售仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213329af963355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213329af963355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIP","BK4007"],"gpt_icon":0},{"id":"2457075040","title":"ANI 制药公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457075040","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457075040?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:32","pubTimestamp":1722951147,"startTime":"0","endTime":"0","summary":"   * ANI Pharmaceuticals Inc   公布的截至6月底的季度调整后每股收益为1.02美元，低于去年同期的每股收益1.28美元。五位分析师对该季度的平均预期为每股收益 95 美分。华尔街预期为每股收益 88 美分至 1.04 美元。* ANI Pharmaceuticals Inc公布的本季度每股收益为亏损14美分。* 该公司当季亏损 269 万美元。* ANI Pharmaceuticals Inc 本季度股价下跌了 7.1%，今年迄今为止上涨了 7.3%。华尔街对 ANI Pharmaceuticals Inc 的 12 个月目标价中位数为 81.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"ANI 制药公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2456528235","title":"ANI Pharmaceuticals Inc   预计每股收益 95 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456528235","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456528235?lang=zh_cn&edition=full","pubTime":"2024-08-02 23:01","pubTimestamp":1722610870,"startTime":"0","endTime":"0","summary":"   * ANI Pharmaceuticals Inc    预计将在8月6日公布截至2024年6月30日的季度收入报告。* LSEG 分析师对 ANI Pharmaceuticals Inc 的平均预期为每股收益 95 美分。* 华尔街对 ANI Pharmaceuticals Inc 的 12 个月目标价中位数为 81.00 美元，高于其上次收盘价 63.85 美元。8月2日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"ANI Pharmaceuticals Inc   预计每股收益 95 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2456235725","title":"Ani Pharmaceuticals, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456235725","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456235725?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:58","pubTimestamp":1722610706,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时58分，Ani Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.07%。截至发稿，该股报60.62美元/股，成交量2.3645万股，换手率0.11%，振幅3.19%。Ani Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为2.21%。其相关个股中，Akanda Corp.、Scilex Holding Company C/Wts 10/11/2027 、Evoke Pharma, Inc.涨幅较大，Akanda Corp.、Redhill Biopharma Ltd、Fsd Pharma Inc.较为活跃，换手率分别为1041.28%、49.50%、12.35%，振幅较大的相关个股有Akanda Corp.、Redhill Biopharma Ltd、Scilex Holding Company C/Wts 10/11/2027 ，振幅分别为28.97%、23.42%、19.94%。Ani Pharmaceuticals, Inc.公司简介：ANI Pharmaceuticals Inc 开发、制造和销售仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802225826af95a936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802225826af95a936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2446365194","title":"HC Wainwright &amp; Co.：维持ANI Pharmaceuticals(ANIP.US)评级，由买入调整至买入评级, 目标价由87.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446365194","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446365194?lang=zh_cn&edition=full","pubTime":"2024-06-26 18:43","pubTimestamp":1719398598,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2446004826","title":"BUZZ-因 ANI 制药公司被收购，Alimera 科学公司股价大涨近 80","url":"https://stock-news.laohu8.com/highlight/detail?id=2446004826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446004826?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:40","pubTimestamp":1719247214,"startTime":"0","endTime":"0","summary":"    6月24日 - ** ANI Pharmaceuticals   提出收购要约后，眼药开发商Alimera Sciences   的股价周一飙升79.3%，达到5.65美元。** ALIM创2022年10月以来新高。2024 年股价将上涨约 11%，目前市值约为 13 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALIM","BK4007","BUZZ","ANIP"],"gpt_icon":0},{"id":"2445075699","title":"【Alimera Sciences(ALIM.US)盘前暴涨超76%！获ANI Pharmaceuticals(ANIP.","url":"https://stock-news.laohu8.com/highlight/detail?id=2445075699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445075699?lang=zh_cn&edition=full","pubTime":"2024-06-24 20:16","pubTimestamp":1719231368,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","ANIP","ALIM"],"gpt_icon":0},{"id":"2445075618","title":"Alimera Sciences(ALIM.US)盘前暴涨超76%！获ANI Pharmaceuticals(ANIP.US)收购 估值3.81亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445075618","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445075618?lang=zh_cn&edition=full","pubTime":"2024-06-24 20:16","pubTimestamp":1719231368,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，ANI Pharmaceuticals宣布，将以每股5.50美元的价格现金收购Alimera Sciences。受此消息提振，截至发稿，Alimera Sciences周一美股盘前涨超76%。ANI Pharmaceuticals表示，此次收购将进一步推动其罕见病业务，并预计该交易将在2025年实现调整后NON-GAAP每股收益的高个位数至低两位数增长，且此后将实现大幅增长。ANI Pharmaceuticals计划使用手头现金和债务融资相结合的方式为此次交易融资。资料显示，ANI Pharmaceuticals开发、制造和销售仿制药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1139706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ALIM","BK4007","ANIP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0361},{"period":"3month","weight":-0.0773},{"period":"6month","weight":-0.0719},{"period":"1year","weight":0.1006},{"period":"ytd","weight":0.0321}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ANI Pharmaceuticals, Inc.于2001年4月成立于特拉华州。该公司是一家综合性的特种制药公司，致力于通过开发，制造和销售高质量的品牌和通用处方药来为公司的客户提供价值。 该公司专注于利基和高入口机会，包括受控物质，抗癌（溶瘤药），激素和类固醇，以及复杂的制剂。 该公司位于明尼苏达州Baudette的两家制药厂能够生产口服固体剂量产品，以及液体和局部，受控物质和必须在完全封闭的环境中制造的有效产品。 该公司的战略是使用其资产开发，收购，制造和销售品牌和通用专业处方药。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.064659},{"month":2,"riseRate":0.416667,"avgChangeRate":0.0136},{"month":3,"riseRate":0.375,"avgChangeRate":-0.029311},{"month":4,"riseRate":0.541667,"avgChangeRate":0.137911},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.019321},{"month":6,"riseRate":0.64,"avgChangeRate":0.036553},{"month":7,"riseRate":0.44,"avgChangeRate":-0.036667},{"month":8,"riseRate":0.44,"avgChangeRate":-0.010558},{"month":9,"riseRate":0.44,"avgChangeRate":0.023941},{"month":10,"riseRate":0.48,"avgChangeRate":-0.035044},{"month":11,"riseRate":0.6,"avgChangeRate":0.085161},{"month":12,"riseRate":0.458333,"avgChangeRate":-0.053943}],"exchange":"NASDAQ","name":"ANI Pharmaceuticals, Inc.","nameEN":"ANI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ANI Pharmaceuticals, Inc.(ANIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ANI Pharmaceuticals, Inc.,ANIP,ANI Pharmaceuticals, Inc.股票,ANI Pharmaceuticals, Inc.股票老虎,ANI Pharmaceuticals, Inc.股票老虎国际,ANI Pharmaceuticals, Inc.行情,ANI Pharmaceuticals, Inc.股票行情,ANI Pharmaceuticals, Inc.股价,ANI Pharmaceuticals, Inc.股市,ANI Pharmaceuticals, Inc.股票价格,ANI Pharmaceuticals, Inc.股票交易,ANI Pharmaceuticals, Inc.股票购买,ANI Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ANI Pharmaceuticals, Inc.(ANIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况